safingol has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurano, M; Sakai, E; Tsukamoto, K; Yatomi, Y | 1 |
| Chen, W; Hang, W; Huang, B; Lin, L; Song, X; Yan, L; Yan, X; Zhang, J | 1 |
2 other study(ies) available for safingol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus.
Topics: Cardiovascular Diseases; Ceramides; Chromatography, Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Sphingolipids; Sphingosine; Tandem Mass Spectrometry; Triglycerides | 2022 |
Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system.
Topics: Adult; Aged; Biomarkers; Chromatography, High Pressure Liquid; Cluster Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Leucine; Male; Metabolome; Metabolomics; Middle Aged; Principal Component Analysis; Spectrometry, Mass, Electrospray Ionization; Sphingosine | 2009 |